Skip to Main Content

Author Details

Sacha Gnjatic
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
1995
228
73
PMIDPaper TitleJournal TitlePublished Year
38057662An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis.Nature2024
38057662An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis.Nature2024
36628884Evaluation of immunological responses to third COVID-19 vaccine among people treated with sphingosine receptor-1 modulators and anti-CD20 therapy.Mult Scler Relat Disord2023
36445014IgG memory B cells expressing IL4R and FCER2 are associated with atopic diseases.Allergy2023
37608772Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: A report of the International Immuno-Oncology Biomarker Working Group on Breast CancerJ Pathol2023
37608771Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.J Pathol2023
37607770Antitumor immunity as the basis for durable disease-free treatment-free survival in patients with metastatic urothelial cancer.J Immunother Cancer2023
37660077Immunophenotypic correlates of sustained MRD negativity in patients with multiple myeloma.Nat Commun2023
37961671Peripheral Transcriptomics in Acute and Long-Term Kidney Dysfunction in SARS-CoV2 Infection.medRxiv2023
36968223A Phase I Trial of VEGF-A Inhibition Combined with PD-L1 Blockade for Recurrent Glioblastoma.Cancer Res Commun2023
36900251Phase I Study of a Multivalent WT1 Peptide Vaccine (Galinpepimut-S) in Combination with Nivolumab in Patients with WT1-Expressing Ovarian Cancer in Second or Third Remission.Cancers (Basel)2023
36707626Germline rare deleterious variant load alters cancer risk, age of onset and tumor characteristics.NPJ Precis Oncol2023
36706355Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease.Blood2023
36813963Autoimmunity in Down's syndrome via cytokines, CD4 T cells and CD11c<sup>+</sup> B cells.Nature2023
36702834Cross center single-cell RNA sequencing study of the immune microenvironment in rapid progressing multiple myeloma.NPJ Genom Med2023
36634824Anti-Integrin αvβ6 Autoantibodies Are a Novel Biomarker That Antedate Ulcerative Colitis.Gastroenterology2023
37069249Circulating proteins to predict COVID-19 severity.Sci Rep2023
37322116Intratumoral dendritic cell-CD4<sup>+</sup> T helper cell niches enable CD8<sup>+</sup> T cell differentiation following PD-1 blockade in hepatocellular carcinoma.Nat Med2023
36628884Evaluation of immunological responses to third COVID-19 vaccine among people treated with sphingosine receptor-1 modulators and anti-CD20 therapy.Mult Scler Relat Disord2023
37308534Proteomic characterization of acute kidney injury in patients hospitalized with SARS-CoV2 infection.Commun Med (Lond)2023
36993735Proteomic Characterization of Acute Kidney Injury in Patients Hospitalized with SARS-CoV2 Infection.Res Sq2023
36919946A methylation clock model of mild SARS-CoV-2 infection provides insight into immune dysregulation.Mol Syst Biol2023
37961671Peripheral Transcriptomics in Acute and Long-Term Kidney Dysfunction in SARS-CoV2 Infection.medRxiv2023
37660077Immunophenotypic correlates of sustained MRD negativity in patients with multiple myeloma.Nat Commun2023
37608772Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: A report of the International Immuno-Oncology Biomarker Working Group on Breast CancerJ Pathol2023
37608771Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.J Pathol2023
37607770Antitumor immunity as the basis for durable disease-free treatment-free survival in patients with metastatic urothelial cancer.J Immunother Cancer2023
36993735Proteomic Characterization of Acute Kidney Injury in Patients Hospitalized with SARS-CoV2 Infection.Res Sq2023
37322116Intratumoral dendritic cell-CD4<sup>+</sup> T helper cell niches enable CD8<sup>+</sup> T cell differentiation following PD-1 blockade in hepatocellular carcinoma.Nat Med2023
37308534Proteomic characterization of acute kidney injury in patients hospitalized with SARS-CoV2 infection.Commun Med (Lond)2023
37069249Circulating proteins to predict COVID-19 severity.Sci Rep2023
36968223A Phase I Trial of VEGF-A Inhibition Combined with PD-L1 Blockade for Recurrent Glioblastoma.Cancer Res Commun2023
36813963Autoimmunity in Down's syndrome via cytokines, CD4 T cells and CD11c<sup>+</sup> B cells.Nature2023
36445014IgG memory B cells expressing IL4R and FCER2 are associated with atopic diseases.Allergy2023
36919946A methylation clock model of mild SARS-CoV-2 infection provides insight into immune dysregulation.Mol Syst Biol2023
36707626Germline rare deleterious variant load alters cancer risk, age of onset and tumor characteristics.NPJ Precis Oncol2023
36900251Phase I Study of a Multivalent WT1 Peptide Vaccine (Galinpepimut-S) in Combination with Nivolumab in Patients with WT1-Expressing Ovarian Cancer in Second or Third Remission.Cancers (Basel)2023
36706355Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease.Blood2023
36634824Anti-Integrin αvβ6 Autoantibodies Are a Novel Biomarker That Antedate Ulcerative Colitis.Gastroenterology2023
36702834Cross center single-cell RNA sequencing study of the immune microenvironment in rapid progressing multiple myeloma.NPJ Genom Med2023
35065058Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial.Lancet Gastroenterol Hepatol2022
36103512A shift in lung macrophage composition is associated with COVID-19 severity and recovery.Sci Transl Med2022
35958514Quantitative chest computed tomography combined with plasma cytokines predict outcomes in COVID-19 patients.Heliyon2022
35697804Rapid, scalable assessment of SARS-CoV-2 cellular immunity by whole-blood PCR.Nat Biotechnol2022
35945129High Dimensional Immune Profiling of Smoldering Multiple Myeloma Distinguishes Distinct Tumor Microenvironments.Clin Lymphoma Myeloma Leuk2022
35623454Neutralizing Anti-Granulocyte Macrophage-Colony Stimulating Factor Autoantibodies Recognize Post-Translational Glycosylations on Granulocyte Macrophage-Colony Stimulating Factor Years Before Diagnosis and Predict Complicated Crohn's Disease.Gastroenterology2022
35734083Evaluation of immunological responses to third COVID-19 vaccine among people treated with sphingosine receptor-1 modulators and anti-CD20 therapy.medRxiv2022
36327219Exome-wide association study to identify rare variants influencing COVID-19 outcomes: Results from the Host Genetics Initiative.PLoS Genet2022
36376796Correction: The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individuals.Clin Proteomics2022
35851878Author Correction: Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery.Nat Med2022
  • 1 - 50 of 456

Recommended Authors

University of California San Francisco
Career Start Year 2018
Number of shared co-authors 2
Massachusetts Institute of Technology
Career Start Year 2013
Number of shared co-authors 2
Stanford Cancer Institute, Stanford School of Medicine
Career Start Year 2010
Number of shared co-authors 7
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year 2010
Number of shared co-authors 10
City of Hope National Medical Center
Career Start Year 2009
Number of shared co-authors 1
UNC School of Medicine, The University of North Carolina at Chapel Hill
Career Start Year 2008
Number of shared co-authors 10
National Cancer Institute
Career Start Year 2005
Number of shared co-authors 4
Memorial Sloan Kettering Cancer Center
Career Start Year 2004
Number of shared co-authors 7
University of Virginia
Career Start Year 2003
Number of shared co-authors 0
Washington University School of Medicine
Career Start Year 2002
Number of shared co-authors 3
University of Colorado Anschutz Medical Campus
Career Start Year 2002
Number of shared co-authors 1
Genentech Inc.
Career Start Year 2002
Number of shared co-authors 3
University Hospital Zurich, University of Zurich
Career Start Year 2000
Number of shared co-authors 2
Jonsson Comprehensive Cancer Center, University of California Los Angeles
Career Start Year 1999
Number of shared co-authors 9
Earle A. Chiles Research Institute, Providence Cancer Institute
Career Start Year 1999
Number of shared co-authors 0
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 4
University of Turin
Career Start Year 1998
Number of shared co-authors 1
National Cancer Institute
Career Start Year 1997
Number of shared co-authors 4
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1995
Number of shared co-authors 10
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1994
Number of shared co-authors 5
University Children's Hospital Muenster
Career Start Year 1994
Number of shared co-authors 0
The Institute of Cancer Research
Career Start Year 1994
Number of shared co-authors 5
University of California san francisco
Career Start Year 1993
Number of shared co-authors 8
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1992
Number of shared co-authors 4
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1991
Number of shared co-authors 5
Convergence Institute, Johns Hopkins University
Career Start Year 1985
Number of shared co-authors 10
Center for Cancer Research, National Cancer Institute
Career Start Year 1984
Number of shared co-authors 13
The University of Texas MD Anderson Cancer Center
Career Start Year 1978
Number of shared co-authors 2
University of Pennsylvania Department of Pathology & Laboratory Medicine
Career Start Year 1978
Number of shared co-authors 9
University of Colorado School of Medicine
Career Start Year 1961
Number of shared co-authors 17

Collaborators

Ludwig Institute for Cancer Research
Co-authored papers 84
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Co-authored papers 49
Icahn School of Medicine at Mount Sinai
Co-authored papers 42
From Population Health Services (Chen)
Co-authored papers 29
Co-authored papers 27
Icahn School of Medicine at Mount Sinai
Co-authored papers 17
Co-authored papers 16
Icahn School of Medicine at Mount Sinai.
Co-authored papers 14
Icahn School of Medicine at Mount Sinai
Co-authored papers 14
New York-Presbyterian Hospital
Co-authored papers 12
Icahn School of Medicine at Mount Sinai
Co-authored papers 10
Hasso Plattner Institute for Digital Health, Icahn School of Medicine at Mount Sinai
Co-authored papers 8
Co-authored papers 8
Icahn School of Medicine at Mount Sinai
Co-authored papers 7
Co-authored papers 7
Co-authored papers 6
University of Hull
Co-authored papers 6
Co-authored papers 6
Ludwig Institute for Cancer Research Ltd.
Co-authored papers 5
University of Southern California
Co-authored papers 5
Icahn School of Medicine at Mount Sinai
Co-authored papers 5
Lady Davis Institute for Medical Research, Jewish General Hospital
Co-authored papers 5
Co-authored papers 5
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
UPMC Hillman Cancer Center
Co-authored papers 4
Yale University School of Medicine
Co-authored papers 4
Memorial Sloan Kettering Cancer Center
Co-authored papers 4